Pembrolizumab/Keytruda: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
mNo edit summary |
||
| Line 20: | Line 20: | ||
== References == | == References == | ||
<references/> | <references/> | ||
Melanie Kusakavitch was a contributing author. | |||